Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,240 | 13,831 | 6,359 | 22,974 | 81,508 |
| Marketable Securities | 53,189 | 55,307 | 68,921 | 58,289 | 4,982 |
| Receivables | 2,053 | 2,537 | 4,398 | 5,324 | 8,668 |
| Inventories | 4,520 | 4,691 | 5,295 | 5,311 | 5,442 |
| Other current assets | 19 | 38 | 37 | 75 | 75 |
| TOTAL | $71,311 | $77,385 | $85,923 | $92,734 | $101,916 |
| Non-Current Assets | |||||
| PPE Net | 2,808 | 2,795 | 2,510 | 2,540 | 2,438 |
| Investments And Advances | 779 | 825 | 950 | 673 | 749 |
| Intangibles | 26,479 | 26,555 | 26,662 | 26,768 | 42,264 |
| Other Non-Current Assets | 7,305 | 5,241 | 952 | 372 | 475 |
| TOTAL | $37,371 | $35,416 | $31,074 | $30,353 | $45,925 |
| Total Assets | $108,682 | $112,801 | $116,997 | $123,086 | $147,841 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,416 | 1,712 | 830 | 952 | 2,056 |
| Accrued Expenses | 1,827 | 1,629 | 1,493 | 934 | 1,512 |
| Other current liabilities | 711 | 744 | 992 | 1,690 | 2,152 |
| TOTAL | $5,098 | $5,116 | $3,610 | $3,873 | $6,012 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 350 | 258 | 18 | N/A | N/A |
| Other Non-Current Liabilities | 2,735 | 3,049 | 1,361 | 1,094 | 1,527 |
| TOTAL | $4,095 | $4,253 | $2,757 | $4,693 | $6,884 |
| Total Liabilities | $9,192 | $9,369 | $6,367 | $8,566 | $12,896 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,018 | 1,025 | 1,008 | 1,030 | 1,030 |
| Common Shares | 35 | 35 | 35 | 35 | 34 |
| Retained earnings | 19,275 | 25,257 | 34,176 | 39,931 | 61,837 |
| Other shareholders' equity | 197 | 329 | 778 | 81 | 6 |
| TOTAL | $99,490 | $103,432 | $110,630 | $114,520 | $134,945 |
| Total Liabilities And Equity | $108,682 | $112,801 | $116,997 | $123,086 | $147,841 |